Astellas Pharma Inc. Selects Dendrite International, Inc. For Sample Compliance Solutions; Dendrite International, Inc.'s Robust And Intuitive Compliance Solutions Chosen To Increase Regulatory Compliance And Accountability Of Prescription Drug Samples

Dendrite International, Inc., (NASDAQ: DRTE) a leading provider of pharmaceutical industry solutions, today announced that Astellas Pharma US, Inc., a pharmaceutical company dedicated to improving the health of populations around the world, signed a three-year contract to outsource its sample accountability and compliance processes to Dendrite.